TGFB1 and myelodysplastic syndrome: Compare to low-risk MDS-MSC, high-risk MDS-MSC is associated with the presence of increased Tregs, increased TGF-β1, higher apoptosis, higher immunosuppressive rate and a poor ability of hematopoietic support.